Details for New Drug Application (NDA): 018762
✉ Email this page to a colleague
The generic ingredient in BRETHAIRE is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
Summary for 018762
Tradename: | BRETHAIRE |
Applicant: | Novartis |
Ingredient: | terbutaline sulfate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018762
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.2MG/INH | ||||
Approval Date: | Aug 17, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018762
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription